Correction: Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany

Related Experiment Video

Updated: Sep 19, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

R Schultz-Heienbrok1, S Baumann2, R Böhm3,4

  • 1Charité Research Organisation GmbH, Berlin, Germany.

Frontiers in Pharmacology
|September 17, 2026
PubMed

Abstract:

[This corrects the article DOI: 10.3389/fphar.2025.1699906.].

Keywords:
clinical trialscomplex trial designfirst-in-humanintegrated protocolsinvestigational medicinal productsubstantial modification

More Related Videos

A Structured Rehabilitation Protocol for Improved Multifunctional Prosthetic Control: A Case Study
06:58

A Structured Rehabilitation Protocol for Improved Multifunctional Prosthetic Control: A Case Study

Published on: November 6, 2015

Related Experiment Videos

Last Updated: Sep 19, 2026

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

A Structured Rehabilitation Protocol for Improved Multifunctional Prosthetic Control: A Case Study
06:58

A Structured Rehabilitation Protocol for Improved Multifunctional Prosthetic Control: A Case Study

Published on: November 6, 2015

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...

Articles linked to this work by shared authors, journal, and citation graph.

The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World Collaborative, Patient-driven Infrastructure for Discovery Research and Precision Oncology.

Research square·2026

Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in Germany.

Frontiers in pharmacology·2026

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conference.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025

Heterogeneity in Dental Tissue-Derived MSCs Revealed by Single-Cell RNA-seq.

Journal of dental research·2024

[Proposal for participation in intensive care and emergency medicine studies for patients unable to give informed consent (Cologne Model)].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2023

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2023

Emerging antibody-drug conjugate (ADC) therapies: perspectives from the global patent landscape.

Frontiers in pharmacology·2026

Potential association between IL-12/23, IL-23, and IL-17 inhibitors and skin cancer: a pharmacovigilance study based on the FAERS database.

Frontiers in pharmacology·2026

Refining absolute GFR estimation in children: development and validation of the GROW-GFR equation.

Frontiers in pharmacology·2026

Quercetin ameliorates gestational diabetes mellitus-induced placental dysfunction by modulating the AGE-RAGE-associated oxidative and inflammatory signaling network.

Frontiers in pharmacology·2026

Time-varying metoprolol exposure and the risk of acute kidney injury: a multicenter retrospective cohort study.

Frontiers in pharmacology·2026

Ginsenosides in hepatocellular carcinoma: preclinical evidence, mechanisms, and clinical implications.

Frontiers in pharmacology·2026

Long Non-Coding RNAs in Tuberculosis: From Pathogenesis to Precision Therapeutics.

Microbial pathogenesis·2026

Recent Progresses in Immune Cell Therapy for Tuberculosis.

Microbial pathogenesis·2026

Progression-Associated Loss of SMARCB1/INI1 Expression in Mismatch Repair-Deficient Glioblastoma.

Neuropathology and applied neurobiology·2026

Dual-layer silk fibroin microneedles with differential solubility for sequential methotrexate release: A topical treatment strategy for psoriasis.

Biomaterials advances·2026

Activity of the natural biflavonoid hinokiflavone against multidrug-resistant CEM/ADR5000 leukemia cells and its modes of action via P-glycoprotein modulation.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

Capillary dried plasma microsampling: A novel approach for therapeutic drug monitoring of tyrosine kinase inhibitors in chronic myeloid leukemia patients by UPLC-MS/MS.

Journal of pharmaceutical and biomedical analysis·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us